Newsroom | 52426 results

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera Presents Positive Preclinical Data on ABCL575 at the SID Annual Meeting 2025...

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company’s Compensation Committee, as material inducements to eleven individuals whose employment commenced in March and April of 2025. The grants resulted in the right to purchase 111,000 shares of the Company’s...

NATICK, Mass.--(BUSINESS WIRE)--AutoIVF Inc., a pioneering fertility care company, has closed an equity investment round, led by Vitrolife Group, with participation from new investors including Alpha Edison and IVF industry stalwarts.  AutoIVF’s flagship product, OvaReady, is a groundbreaking automated system that simplifies and enhances egg retrieval and preparation in the current IVF process and supports decentralizing the egg retrieval process outside traditional IVF laboratory settings. Acc...

UPPER NYACK, N.Y.--(BUSINESS WIRE)--En una conferencia médica para profesionales de vacunas, las publicaciones en redes sociales, los podcasts y los videos de YouTube de la Global Healthy Living Foundation (GHLF) tuvieron una sorprendente acogida entre pacientes con enfermedades crónicas, a pesar de la retórica anti-vacunas persistente proveniente de medios, individuos y fuentes gubernamentales. La cobertura de GHLF del Congreso Mundial de Vacunas, celebrado la semana pasada en Washington, D.C....

EWING, N.J.--(BUSINESS WIRE)--Universal Display Corporation announced it will exhibit and present at SID Display Week 2025....

DUBLIN--(BUSINESS WIRE)--The "Artificial Intelligence (AI) in Drug Discovery Market - Global Outlook & Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The Artificial Intelligence (AI) in Drug Discovery Market was valued at USD 1.72 billion in 2024, and is projected to reach USD 8.53 billion by 2030, rising at a CAGR of 30.59%. The global AI in drug discovery market has witnessed significant growth in recent years as pharmaceutical companies increasingly adopt...

CAMBRIDGE, England & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Lightcast announced the limited commercial release of its Envisia™ platform — a breakthrough droplet-based, single-cell functional analysis system....

CORNING, N.Y.--(BUSINESS WIRE)--Corning Incorporated (NYSE: GLW) and Samsung Electronics Co., Ltd. today announced that the upcoming Galaxy S25 Edge will feature Corning® Gorilla® Glass Ceramic 21, a new glass ceramic offering that delivers advanced protection in a new, remarkably thin device form factor. Driven by a shared vision to push the boundaries of mobile engineering, Samsung and Corning joined forces to ensure the premium S series experience balances elegance with resilience. Gorilla G...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced 24-week post-end of treatment data from Part B of the ongoing MARCH Phase 2 clinical study evaluating tobevibart and elebsiran without or with pegylated interferon alpha (PEG-IFNα) in participants with chronic hepatitis B (CHB). The study-defined primary endpoint, proportion of participants with undetectable hepatitis B surface antigen (HBsAg) at 24 weeks post-end of treatment, was achieved by 17% (3/18) and 2...

MENLO PARK, California--(BUSINESS WIRE)--Elegen, líder en la fabricación de ADN sin células de última generación, anunció hoy el lanzamiento de acceso anticipado ENFINIA™ IVT Ready DNA. Este nuevo producto es una ampliación de su plataforma ENFINIA; se entrega listo para usar con la cola de poli(A) necesaria ya codificada. Su disponibilidad comercial está prevista a escala mundial para principios del verano de 2025. Basado en la tecnología sin células patentada de Elegen, ENFINIA IVT Ready DNA,...